Respiratory Syncytial Virus (RSV)

  • New Perspectives for Development of an RSV Vaccine
    Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus ...More
    October 16, 2014 Posted in News
  • A New Breakthrough in RSV Research
    The New England Journal of Medicine published research results today from a clinical trial of a drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with respiratory syncytial virus (RSV). Le Bonheur ...More
    August 28, 2014 Posted in News
  • Breakthrough in RSV Research to Help Infected Children
    Researchers at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center announced results from a clinical trial of a drug shown to safely reduce the viral load and clinical illness of healthy adult volunteers intranasally infected with ...More
    May 26, 2014 Posted in News
  • Researcher Receives $2.83 Million Grant to Develop Drugs for Prevention, Treatment of RSV Infection
    Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory Syncytial Virus (RSV) infection. The grant from the Eunice ...More
    April 25, 2014 Posted in News
  • Ginseng Can Treat and Prevent Influenza and RSV
    Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research findings by a scientist in Georgia State University's new Institute for Biomedical Sciences. In a ...More
    April 21, 2014 Posted in News
  • Researchers Find Genetic Trigger for RSV-Induced Infant Hospitalizations
    Researchers at UNC School of Medicine have pinpointed a viral protein that plays a major role in making respiratory syncytial virus (RSV) the most common cause of hospitalization in children under 1 year of age. The discovery, published April 8 in the Journal of ...More
    April 8, 2014 Posted in News
  • Scripps Research Institute Scientists Create Potential Vaccine Ingredient for RSV
    Scientists at the Scripps Research Institute (TSRI) have invented a new method for designing artificial proteins, and have used it to make key ingredients for a candidate vaccine against a dangerous virus, respiratory syncytial virus (RSV), a significant cause of infant ...More
    February 5, 2014 Posted in News
  • Imaging Technology Could Unlock Mysteries of RSV
    By the time they're 2 years old, most children have had respiratory syncytial virus (RSV) and suffered symptoms no worse than a bad cold. But for some children, especially premature babies and those with underlying health conditions, RSV can lead to pneumonia and bronchitis ...More
    January 2, 2014 Posted in News
  • RSV Often Milder Than Flu in Older Adults
    Respiratory Syncytial Virus (RSV) appears to cause milder illness than influenza in adults age 50 or older, according to researchers at Marshfield Clinic Research Foundation. The study, published online in Clinical Infectious Diseases, also shows RSV is a common cause of ...More
    December 22, 2013 Posted in News
  • Genetic Signature Identified for RSV, the Leading Cause of Infant Hospitalizations Worldwide
    Scientists have identified the genetic signature of respiratory syncytial virus (RSV), the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a ...More
    November 14, 2013 Posted in News
« Previous123Next »